SMARCA5 and Familial prostate cancer: To test the clinical significance of these relationships, we used partial correlation analyses to demonstrate that BAZ1A and SMARCA5 expression, as well as other VDR-interacting proteins identified in cell lines by RIME, were able to significantly strengthen the correlations between VDR and AA cistrome genes in AA prostate cancer.